The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 401–500 of 1,000
Italiani, V. C. S., Neto, J. F. D. S., Braz, V. S., & Marques, M. V. (2011) · Journal of Bacteriology · doi:10.1128/jb.01339-10 · Cited by 59
Xu, X., Vilchèze, C., Av-Gay, Y., Gómez-Velasco, A., & Jacobs, W. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00020-11 · Cited by 52
Jittawuttipoka, T., Buranajitpakorn, S., Vattanaviboon, P., & Mongkolsuk, S. (2009) · Journal of Bacteriology · doi:10.1128/jb.00788-09 · Cited by 52
Joshi, S. D., Kumar, D., Dixit, S. R., Tigadi, N., More, U. A., Lherbet, C., Aminabhavi, T. M., & Yang, K. S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.025 · Cited by 52
Liu, L., Jiang, F., Chen, L., Zhao, B. T., Dong, J., Sun, L., Zhu, Y., Liu, B., Zhou, Y., Yang, J., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0184-0 · Cited by 52
Characterization and virulence analysis of catalase mutants of Haemophilus influenzae
Bishai, W. R., Howard, N. S., Winkelstein, J. A., & Smith, H. O. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.4855-4860.1994 · Cited by 52
Challenges in the development of drugs for the treatment of tuberculosis
Shehzad, A., Rehman, G., Ul‐Islam, M., Khattak, W. A., & Lee, Y. S. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.10.009 · Cited by 55
Tuberculosis and other mycobacterial infections
Friedland, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00030-7 · Cited by 51
Nikolayevskyy, V., Brown, T., Bazhora, Y. I., Asmolov, A., Balabanova, Y., & Drobniewski, F. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01583.x · Cited by 51
Judge, V., Narasimhan, B., Ahuja, M., Sriram, D., Yogeeswari, P., Clercq, E. D., Pannecouque, C. C., & Balzarini, J. M. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9705-2 · Cited by 51
Analysis of Heme Structural Heterogeneity in Mycobacterium tuberculosis Catalase-Peroxidase (KatG)
Chouchane, S., Girotto, S., Kapetanaki, S. M., Schelvis, J. P. M., Yu, S., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208256200 · Cited by 54
Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases
Singh, A. K., Kumar, R. P., Pandey, N., Singh, N., Sinha, M., Bhushan, A., Kaur, P., Sharma, S. P., & Singh, T. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060327 · Cited by 51
García, E. G., Nedialkov, Y. A., Elliott, J. M., Леонидович, М. В., & Brubaker, R. R. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.10.3114-3122.1999 · Cited by 51
Hahn, J.-S., Oh, S.-Y., & Roe, J.-H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.13.3767-3774.2000 · Cited by 50
Proteins and Antigens ofMycobacterium tuberculosis
Andersen, Å. B., & Brennan, P. J. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch21 · Cited by 51
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid
Rosner, J. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2251 · Cited by 51
Hu, Y., Hoffner, S. E., Jiang, W., Wang, W., & Xu, B. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-43 · Cited by 50
Li, Q., Zhou, M., Fan, X., Yan, J., Li, W., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep28701 · Cited by 52
Parrish, N. M., Houston, T. A., Jones, P. B., Townsend, C. A., & Dick, J. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1143-1150.2001 · Cited by 50
Master, S. S., Zahrt, T. C., Song, J., & Deretic, V. P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.13.4033-4039.2001 · Cited by 50
Caws, M., & Drobniewski, F. A. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb11371.x · Cited by 50
Spatial patterns of tuberculosis incidence in Cologne (Germany)
Kistemann, T., Munzinger, A., & Dangendorf, F. (2002) · Social Science & Medicine · doi:10.1016/s0277-9536(01)00216-7 · Cited by 50
An effective nano drug delivery and combination therapy for the treatment of Tuberculosis
Sheikhpour, M., Delorme, V., Kasaeian, A., Amiri, V., Masoumi, M., Sadeghinia, M. J., Ebrahimzadeh, N., Maleki, M., & Dizaji, S. P. (2022) · Scientific Reports · doi:10.1038/s41598-022-13682-4 · Cited by 50
Timmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.16.5427-5431.2004 · Cited by 49
Molecular Diagnosis of Tuberculosis and Drug Resistance
Lin, S.-Y. G., & Desmond, E. P. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.02.005 · Cited by 49
Drug development against tuberculosis: Past, present and future
Vasava, M. S., Bhoi, M. N., Rathwa, S. K., Borad, M. A., Nair, S., & Patel, H. D. (2017) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2017.03.002 · Cited by 52
Ates, L. S., Dippenaar, A., Sayes, F., Pawlik, A., Bouchier, C., Ma, L., Warren, R. M., Sougakoff, W., Majlessi, L., van Heijst, J. W. J., et al. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy145 · Cited by 56
Choudhuri, B. S., Sen, S., & Chakrabarti, P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0357 · Cited by 49
Nagy, J. M., Cass, A. E. G., & Brown, K. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31265 · Cited by 49
Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9
Meijers, A. S., Troost, R., Ummels, R., Maaskant, J. J., Speer, A., Nejentsev, S., Bitter, W., & Kuijl, C. P. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101983 · Cited by 51
CinA mediates multidrug tolerance in Mycobacterium tuberculosis
Kreutzfeldt, K. M., Jansen, R. S., Hartman, T. E., Gouzy, A., Wang, R., Krieger, I. V., Zimmerman, M. D., Gengenbacher, M., Sarathy, J. P., Xie, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29832-1 · Cited by 54
Koshkin, A., Knudsen, G. M., & de Montellano, P. R. O. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.017 · Cited by 48
Mariam, S. H., Werngren, J., Aronsson, J., Hoffner, S. E., & Andersson, D. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021147 · Cited by 48
Hou, L., Osei‐Hyiaman, D., Zhang, Z., Wang, B., YANG, A., & KANO, K. (2000) · Epidemiology and Infection · doi:10.1017/s0950268899003635 · Cited by 48
Goyal, M., Young, D. B., Zhang, Y., Jenkins, P. A., & Shaw, R. J. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.12.3070-3071.1994 · Cited by 48
Self-citationHorizontal transfer of catalase-peroxidase genes between Archaea and pathogenic bacteria
Faguy, D. M., & Doolittle, W. F. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02007-2 · Cited by 55
Dahl, J. L., Wei, J., Moulder, J. W., Laal, S., & Friedman, R. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4295-4302.2001 · Cited by 48
Ali, A., Hasan, R., Jabeen, K., Jabeen, N., Qadeer, E., & Hasan, Z. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05101-11 · Cited by 47
Horváti, K., Bacsa, B., Kiss, É., Gyulai, G., Fodor, K., Balka, G., Rusvai, M., Szabó, E., Hudecz, F., & Bősze, S. E. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500476x · Cited by 53
Kikuchi, N., Reed, A. J., Gerasimova, Y. V., & Kolpashchikov, D. M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03964 · Cited by 47
The Mycobacterial Thioredoxin Peroxidase Can Act as a One-cysteine Peroxiredoxin
Trujillo, M., Mauri, P., Benazzi, L., Comini, M., De Palma, A., Flohé, L., Radi, R., Stehr, M., Singh, M., Ursini, F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601008200 · Cited by 47
Drug-Resistant Tuberculosis in Pediatrics
Swanson, D. S., & Starke, J. R. (1995) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38979-9 · Cited by 51
Aspirin Antagonism in Isoniazid Treatment of Tuberculosis in Mice
Byrne, S. T., Denkin, S. M., & Zhang, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-06 · Cited by 46
Self-citationHigher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection
Hakamata, M., Takihara, H., Iwamoto, T., Tamaru, A., Hashimoto, A., Tanaka, T., Kaboso, S. A., Gebretsadik, G., Ilinov, A., Yokoyama, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75028-2 · Cited by 51
Carpena, X., Wiseman, B., Deemagarn, T., Herguedas, B., Ivancich, A., Singh, R., Loewen, P. C., & Fita, I. (2006) · Biochemistry · doi:10.1021/bi060017f · Cited by 46
Zhang, Z., Hillas, P. J., & de Montellano, P. R. O. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1056 · Cited by 46
Riley, L. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_2.s442 · Cited by 46
Zhao, X., Suárez, J., Khajo, A., Yu, S., Metlitsky, L., & Magliozzo, R. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103311e · Cited by 45
Gomgnimbou, M. K., Hernández-Neuta, I., Panaiotov, S., Bachiyska, E., Palomino, J. C., Martin, A., Portillo, P. D., Refrégier, G., & Sola, C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01523-13 · Cited by 45
Dandawate, P. R., Vemuri, K., Khan, E. M., Sritharan, M., & Padhyé, S. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.006 · Cited by 45
Torres, M. J., Criado, A. J., Ruíz, M., Llanos, A. C., Palomares, J. C., & Aznar, J. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00521-7 · Cited by 49
Nikolayevskyy, V., Brown, T. S., Balabanova, Y., Ruddy, M., Fedorin, I., & Drobniewski, F. A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4498-4502.2004 · Cited by 45
Fang, Z., Doig, C., Rayner, A. W., Kenna, D., Watt, B., & Forbes, K. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.998-1003.1999 · Cited by 45
Luo, T., Jiang, L., Sun, W., Fu, G., Mei, J., & Gao, Q. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02046-10 · Cited by 44
Mycobacterium tuberculosispellicles express unique proteins recognized by the host humoral response
Kerns, P. W., Ackhart, D. F., Basaraba, R. J., Leid, J. G., & Shirtliff, M. E. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12142 · Cited by 44
Argyrou, A., Vetting, M. W., & Blanchard, J. S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073160k · Cited by 44
Bardou, F., Quémard, A., Dupont, M. A., Horn, C., Marchal, G., & Daffé, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2459 · Cited by 43
Leung, E. T. Y., Ho, P., Yuen, K., Woo, W. L., Lam, T., Kao, R. Y. T., Seto, W., & Yam, W. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1075-1078.2006 · Cited by 44
Gebhard, S., Hümpel, A., McLellan, A. D., & Cook, G. M. (2008) · Microbiology · doi:10.1099/mic.0.2008/018044-0 · Cited by 54
Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives
Ertan‐Bolelli, T., Yıldız, İ., & Özgen, S. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1499-1 · Cited by 44
Victor, T. C., Warren, R. M., BUTT, J. L., Jordaan, A. M., FELIX, J. V., Venter, A., Sirgel, F. A., Schaaf, H. S., Donald, P. R., Richardson, M., et al. (1997) · Journal of Medical Microbiology · doi:10.1099/00222615-46-10-847 · Cited by 44
Kardan-Yamchi, J., Kazemian, H., Haeili, M., Harati, A. A., Amini, S., & Feizabadi, M. M. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.01.003 · Cited by 56
Rastogi, N., & David, H. L. (1993) · Research in Microbiology · doi:10.1016/0923-2508(93)90028-z · Cited by 43
Delaine, T., Bernardes‐Génisson, V., Quémard, A., Constant, P., Meunier, B., & Bernadou, J. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.016 · Cited by 43
Deemagarn, T., Carpena, X., Singh, R., Wiseman, B., Fita, I., & Loewen, P. C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.020 · Cited by 43
Hanoulle, X., Wieruszeski, J., Rousselot‐Pailley, P., Landrieu, I., Baulard, A. R., & Lippens, G. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.197 · Cited by 43
Maddry, J. A., Suling, W. J., & Reynolds, R. C. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80211-7 · Cited by 43
Nunn, C. M., Djordjević, S., Hillas, P. J., Nishida, C. R., & de Montellano, P. R. O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200864200 · Cited by 43
Jiang, X., Zhang, W., Gao, F., Huang, Y., Lv, C., & Wang, H. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.231 · Cited by 42
Gene Transfer in Mycobacterium tuberculosis : Shuttle Phasmids to Enlightenment
Jacobs, W. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0037-2013 · Cited by 42
Kamal, Ä., Azeeza, S., Malik, M. S., Shaik, A. A., & Rao, M. V. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j36k5k · Cited by 46
Abrahams, K. A., & Besra, G. S. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00261e · Cited by 44
Jayaraman, M., Loganathan, L., Muthusamy, K., & Ramadas, K. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116204 · Cited by 42
Alcaraz, M., Sharma, B., Roquet, F., Condé, C., Cochard, T., Biet, F., Kumar, V., & Kremer, L. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114531 · Cited by 42
Carette, X., Blondiaux, N., Willery, E., Hoos, S., Lecat‐Guillet, N., Lens, Z., Wohlkönig, A., Wintjens, R. T., Soror, S. H. A., Frénois, F., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1113 · Cited by 46
Tuberculose resistente: revisão molecular
Rossetti, M. L. R., Valim, A. R. D. M., Silva, M. S. N., & Rodrigues, V. D. F. S. (2002) · Revista de Saúde Pública · doi:10.1590/s0034-89102002000400021 · Cited by 42
Koshkin, A., Nunn, C. M., Djordjević, S., & de Montellano, P. R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303747200 · Cited by 42
Al-Mutairi, N. M., Ahmad, S., & Mokaddas, E. M. (2011) · PubMed · Cited by 41
Laborde, J., Deraeve, C., & Bernardes‐Génisson, V. (2017) · ChemMedChem · doi:10.1002/cmdc.201700424 · Cited by 41
Logu, A. D., Uda, P., Pellerano, M. L., Pusceddu, M. C., Saddi, B., & Schivo, M. L. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011234 · Cited by 43
Rosner, J. L., & Storz, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1829 · Cited by 43
Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery
Awasthi, D., & Freundlich, J. S. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.05.007 · Cited by 40
Pérez-Osorio, A. C., Boyle, D. S., Ingham, Z. K., Ostash, A., Gautom, R., Colombel, C., Houze, Y. B., & Leader, B. T. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05570-11 · Cited by 43
Gupta, A., Bhakta, S., Kundu, S., Gupta, M., Srivastava, B. S., & Srivastava, R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp279 · Cited by 40
The structure and function of the isoniazid target in M. tuberculosis
Sacchettini, J. C., & Blanchard, J. S. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80201-4 · Cited by 40
Morris, S. L., Nair, J., & Rouse, D. A. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-11-2363 · Cited by 40
Chetty, S., Armstrong, T., Kharkwal, S. S., Drewe, W. C., Matteis, C. I. D., Evangelopoulos, D., Bhakta, S., & Thomas, N. R. (2021) · Pharmaceuticals · doi:10.3390/ph14040361 · Cited by 39
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India
Unissa, A. N., Selvakumar, N., Narayanan, S., & Narayanan, P. R. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.013 · Cited by 39
Angelova, V. T., Valcheva, V., Pencheva, T., Voynikov, Y., Vassilev, N. G., Mihaylova, R., Momekov, G., & Shivachev, B. L. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.011 · Cited by 39
Marsh, I. B., & Whittington, R. J. (2006) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2006.08.002 · Cited by 39
Shi, R., Otomo, K., Yamada, H., Tatsumi, T., & Sugawara, I. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.06.008 · Cited by 40
Basso, L. A., Zheng, R., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja962035y · Cited by 39
Crucial components of mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors
Duan, X., Xiang, X., & Xie, J. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12597 · Cited by 40
Montelongo-Peralta, L. Z., León‐Buitimea, A., Palma‐Nicolás, J. P., González‐Christen, J., & Morones‐Ramírez, J. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-42049-5 · Cited by 38
Antitubercular Triazines: Optimization and Intrabacterial Metabolism
Wang, X., Inoyama, D., Russo, R., Li, S.-G., Jadhav, R. D., Stratton, T. P., Mittal, N., Bilotta, J. A., Singleton, E., Kim, T., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.10.010 · Cited by 40
Reingewertz, T. H., Meyer, T., McIntosh, F. A., Sullivan, J., Meir, M., Chang, Y., Behr, M. A., & Barkan, D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01899-19 · Cited by 38
Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
Goff, A., Cantillon, D. M., Wildner, L. M., & Waddell, S. J. (2020) · Applied Sciences · doi:10.3390/app10134629 · Cited by 39
Stec, J., Vilchèze, C., Lun, S., Perryman, A. L., Wang, X., Freundlich, J. S., Bishai, W. R., Jacobs, W. R., & Kozikowski, A. P. (2014) · ChemMedChem · doi:10.1002/cmdc.201402255 · Cited by 38
Ramírez, L. M. N., Mehaffy, C., Creissen, E., Troudt, J. M., Troy, A., Bielefeldt‐Ohmann, H., Burgos, M. V., Izzo, A. A., & Dobos, K. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166807 · Cited by 40
Vijay, S., Nair, R. R., Sharan, D., Jakkala, K., Mukkayyan, N., Swaminath, S., Pradhan, A., Joshi, N. V., & Ajitkumar, P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00463 · Cited by 39
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.